Cargando…

SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility

Several reports claim that the purported similarity between syncytin-1 and the SARS-CoV-2 spike protein may induce immune cross-reactivity resulting in female sterility. We used frozen embryo transfer as a model for comparing the implantation rates between SARS-CoV-2 vaccine seropositive, infection...

Descripción completa

Detalles Bibliográficos
Autor principal: Morris, Randy S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169568/
https://www.ncbi.nlm.nih.gov/pubmed/34095871
http://dx.doi.org/10.1016/j.xfre.2021.05.010
_version_ 1783702076463775744
author Morris, Randy S.
author_facet Morris, Randy S.
author_sort Morris, Randy S.
collection PubMed
description Several reports claim that the purported similarity between syncytin-1 and the SARS-CoV-2 spike protein may induce immune cross-reactivity resulting in female sterility. We used frozen embryo transfer as a model for comparing the implantation rates between SARS-CoV-2 vaccine seropositive, infection seropositive, and seronegative women. No difference was found in serum hCG documented implantation rates or sustained implantation rates between the three groups. Reports claiming that COVID-19 vaccines or illness cause female sterility are unfounded.
format Online
Article
Text
id pubmed-8169568
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-81695682021-06-02 SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility Morris, Randy S. F S Rep Special Contribution Several reports claim that the purported similarity between syncytin-1 and the SARS-CoV-2 spike protein may induce immune cross-reactivity resulting in female sterility. We used frozen embryo transfer as a model for comparing the implantation rates between SARS-CoV-2 vaccine seropositive, infection seropositive, and seronegative women. No difference was found in serum hCG documented implantation rates or sustained implantation rates between the three groups. Reports claiming that COVID-19 vaccines or illness cause female sterility are unfounded. Elsevier 2021-06-02 /pmc/articles/PMC8169568/ /pubmed/34095871 http://dx.doi.org/10.1016/j.xfre.2021.05.010 Text en © 2021 Published by Elsevier Inc. on behalf of American Society for Reproductive Medicine. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Special Contribution
Morris, Randy S.
SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility
title SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility
title_full SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility
title_fullStr SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility
title_full_unstemmed SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility
title_short SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility
title_sort sars-cov-2 spike protein seropositivity from vaccination or infection does not cause sterility
topic Special Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169568/
https://www.ncbi.nlm.nih.gov/pubmed/34095871
http://dx.doi.org/10.1016/j.xfre.2021.05.010
work_keys_str_mv AT morrisrandys sarscov2spikeproteinseropositivityfromvaccinationorinfectiondoesnotcausesterility